ADVANCED SOLID TUMORS
Clinical trials for ADVANCED SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to reawaken immune cells against tough cancers
Disease control OngoingThis study tests a new drug, ASP1570, in adults with advanced solid tumors that have not responded to standard treatments. The drug is given alone or with other cancer therapies to see if it can help the immune system fight the cancer. The main goals are to check safety and find …
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Apr 29, 2026 02:40 UTC
-
New drug targets tough cancers with KRAS G12V mutation
Disease control OngoingThis early-phase study tests a new drug, QTX3544, in people with advanced solid tumors that have a specific genetic mutation called KRAS G12V. The main goals are to check the drug's safety and how well it works, either alone or with another drug called cetuximab. About 237 partic…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: Quanta Therapeutics • Aim: Disease control
Last updated Apr 29, 2026 02:39 UTC
-
First human trial of PRL3-ZUMAB aims to find safe dose for advanced cancers
Disease control OngoingThis study tests the safety of a new drug, PRL3-ZUMAB, in people with advanced solid tumors that have not responded to standard treatments. It is the first time this drug is given to humans, after showing good tolerance in animals. The main goal is to find the safest dose and che…
Matched conditions: ADVANCED SOLID TUMORS
Phase: PHASE1 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Apr 29, 2026 02:38 UTC